Calcium and vitamin D: Current developments in the prevention of osteoporosis and osteomalacia

Current Opinion in Orthopaedics

Volumn 15, Issue 5, 2004, Pages 383-388

  Nieves, Jeri W ^a,b  

^a HELEN HAYES HOSPITAL   (United States)

^b Columbia University ^*  (United States)

Author keywords

Calcium; Falls; Fractures; Rickets; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; VITAMIN D;

AGE; AGED; BONE MASS; CALCIUM INTAKE; CLINICAL TRIAL; FALLING; FEMALE; FRAGILITY FRACTURE; HUMAN; OSTEOMALACIA; OSTEOPOROSIS; PAIN; POSTMENOPAUSE; PRIORITY JOURNAL; PUBLICATION; REVIEW; RICKETS; SEASONAL VARIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 4544282641     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bco.0000140972.42005.7e     Document Type: Review

References (54)

1. Nieves JW: 'Nutrition and Osteoporosis' in Osteoporosis: An Evidence Based Approach to the Prevention and Management. Edited by Cummings S, Cosman F, Jamal S. Philadelphia: American College of Physicians; 2002.
2. Cummings RG, Nevitt MC: Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res 1997, 12:1321-1329.
3. Recker RR, Hinders S, Davies KM, et al.: Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996, 11:1961-1966.
4. Reid IR, Ames RW, Evans MC, et al.: Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial. Am J Med 1995, 98:331-335.
5. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670-676.
6. Chapuy MC, Arlot ME, Duboeuf F, et al.: Vitamin D and calcium to prevent hip fractures in elderly women. N Engl J Med 1 992, 327:1637-1642.
7. Komulainen MH, Kroger H, Tuppurainen MT, et al.: HRT and Vitamin D in prevention of non-vertebral fractures in postmenopausal women. A 5 year randomized trial. Maturitas 1998, 31:45-54.
8. Chevalley T, Rizzoli R, Nydegger V, et al.: Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin D replete elderly patients. Osteoporos Int 1994, 4:245-252.
9. Lips P, Graafmans WC, Ooms ME, et al.: Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996, 124:400-406.
10. Nieves JW: Calcium, vitamin D, and nutrition in elderly adults. Clin Geriatr Med 2003, 19:321-335.
11. Malabanan AO, Holick MF: Vitamin D and bone health in postmenopausal women. J Womens Health 2003, 12:151-156.
12. Bischoff HA, Dietrich T, Orav EJ, et al.: Higher 25-hydroxyvitamin D levels are associated with inactive and active ambulatory elderly in the US. ASBMR 2003 Meeting.
13. Dawson-Hughes B, Heaney RP, Holick M, et al.: Vitamin D roundtable. In Nutritional Aspects of Osteoporosis. Edited by Burckhardt, Dawson-Hughes, Heany. San Diego: Academic Press; 2004.
14. Allain TJ, Dhesi J: Hypovitaminosis D in older adults. Gerontology 2003, 49:273-278.
15. Elliott ME, Binkley NC, Carnes M, et al.: Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy 2003, 23:702-710. In a skilled nursing facility, in 49 women aged 68 to 100 years, 60% (95% CI 46-74%) had 25-hydroxyvitamin D levels of 20 ng/ml or less, which is associated with secondary hyperparathyroidism; only 4% of women had levels above 30 ng/ml, recently recommended as optimal. Vitamin D status was suboptimal even in most women taking multivitamins. The high prevalence of vitamin D deficiency, even in those women taking multivitamins, indicates that practical new approaches for vitamin D repletion in this population are urgently needed.
16. Bhattoa HP, Bettembuk P, Ganacharya S, Balogh A: Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Osteoporos Int 2004, 15:447-451 (Epub 2003 Dec 23).
17. Isaia G, Giorgino R, Rini GB, et al.: Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 2003, 14:577-582.
18. Passeri G, Pini G, Troiano L, et al.: Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003, 88:5109-5115. Centenarians, 104 subjects over 98 years of age, were studied to evaluate possible interventions to avoid fragility fractures. Serum 25-hydroxyvitamin D was undetectable in 99 of 104 centenarians. Thus, the extreme decades of life are characterized by a vitamin D deficiency, low serum calcium, and secondary hyperparathyroidism with an increase in bone resorption and severe osteopenia. There is a potential prevention of osteoporotic fractures and fracture-induced disability through the supplementation with calcium and vitamin D.
19. Holick MF: Vitamin D deficiency: What a pain it is. Mayo Clin Proc 2003, 78:12.
20. Sullivan SS, Rosen CJ, Chen TC, Holick MF: Seasonal changes in serum 25(OH)D in adolescent girls in Maine. J Bone Miner Res 2003, 18:S407.
21. Gartner LM, Greer FR: Section on Breastfeeding and Committee on Nutrition. American Academy of Pediatrics. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics 2003, 111:908-910. Rickets in infants attributable to inadequate vitamin D intake and decreased exposure to sunlight continues to be reported in the United States. It is recommended that all infants, including those who are exclusively breastfed, have a minimum intake of 200 IU of vitamin D per day beginning during the first 2 months of life. In addition, it is recommended that an intake of 200 IU of vitamin D per day be continued throughout childhood and adolescence, because adequate sunlight exposure is not easily determined for a given individual. These new vitamin D intake guidelines for healthy infants and children are based on the recommendations of the National Academy of Sciences.
22. Balasubramanian K, Rajeswari J, Gulab, et al.: Varying role of vitamin D deficiency in the etiology of rickets in young children vs. adolescents in northern India. J Trop Pediatr 2003, 49:201-206.
23. Basha B, Rao DS, Han ZH, Parfitt AM: Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 2000, 108:296-300.
24. Plotnikoff GA, Quigley JM: Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003, 78:1463-1470. All patients with persistent, nonspecific musculoskeletal pain are at high risk for the consequences of unrecognized and untreated severe hypovitaminosis D. This risk extends to those considered at low risk for vitamin D deficiency. Nonimmigrant women of childbearing age with such pain appear to be at greatest risk for misdiagnosis or delayed diagnosis. Because osteomalacia is a known cause of persistent, nonspecific musculoskeletal pain, screening all outpatients with such pain for hypovitaminosis D should be standard practice in clinical care.
25. El-Desouki MI, Othman SM, Fouda MA: Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J 2004, 25:355-358.
26. Moreland JD, Richardson JA, Goldsmith CH, Clase CM: Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2004, 52:1121-1129. A recent review evaluated and summarized the evidence of muscle weakness as a risk factor for falls in older adults. Thirty studies met the selection criteria; data were available from 13. For lower-extremity weakness, the combined OR was 1.76 (95% confidence interval (CI) = 1.31-2.37) for any fall and 3.06 (95% CI = 1.86-5.04) for recurrent falls. For upper-extremity weakness the combined OR was 1.53 (95% CI = 1.01-2.32) for any fall and 1.41 (95% CI = 1.25-1.59) for recurrent falls. The authors conclude that muscle strength (especially lower extremity) should be one of the factors that is assessed and treated in older adults at risk for falls. More clinical trials are needed to isolate whether muscle-strengthening exercises are effective in preventing falls.
27. Tinetti ME: Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003, 348:42-49.
28. Sambrook PN, Chen JS, March LM, et al.: Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 2004, 89:1572-1576.
29. Bischoff HA, Stahelin HB, Dick W, et al: Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003, 18:343-351.
30. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al.: Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999-2006. The goal of this study was to assess the effectiveness of vitamin D in preventing an older person from falling; 5 of 38 identified studies were included in the primary analysis. Fifteen patients would need to be treated with vitamin D to prevent 1 person from falling. Vitamin D supplementation appears to reduce the risk of falls among ambulatory or institutionalized older individuals with stable health by more than 20%.
31. Michaelsson K, Melhus H, Bellocco R, Wolk A: Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 2003, 32:694-703.
32. Feskanish D, Willett WC, Colditz GA: Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 2003, 77:504-511.
33. Xu L, McElduff P, D'Este C, Attia J: Does dietary calcium have a protective effect on bone fractures in women? A meta-analysis of observational studies. Br J Nutr 2004, 91:625-634.
34. Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469. This was a randomized double-blind controlled trial of 100 000 IU oral vitamin D3 (cholecalciferol) supplementation or matching placebo every 4 months over 5 years in 2037 men and 649 women aged 65 to 85 years. Four monthly supplementations with 100,000 IU oral vitamin D may prevent fractures without adverse effects in men and women living in the general community.
35. Szulc P, Meunier PJ: Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. Joint Bone Spine 2003, 70:157-160.
36. Larsen ER, Mosekilde I, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: A pragmatic population-based 3 year intervention study. J Bone Miner Res 2004, 19:370-378. In this study of 9605 community-dwelling Danish residents the authors reported that 400 IU vitamin D and 1000 mg of calcium supplements significantly reduced fracture risk by 16% in this Northern European region that is known to be deficient in vitamin D.
37. Rozen GS, Rennert G, Dodiuk-Gad RP, et al.: Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. Am J Clin Nutr 2003, 78:993-998.
38. Valimaki VV, Alfthan H, Lehmuskallio E, et al.: Vitamin D status as a determinant of peak bone mass in young Finnish men. J Clin Endocrinol Metab 2004, 89:76-80. Serum 25-OHD concentrations were positively correlated with bone mineral content at each skeletal site. The authors conclude that vitamin D deficiency is very common in Finnish young men in the winter, and it may have detrimental effects on the acquisition of maximal peak bone mass.
39. Grados F, Brazier M, Kamel S, et al.: Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 2003, 88:5175-5179.
40. Cooper L, Clifton-Bligh PB, Nery ML, et al.: Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 2003, 77:1324-1329.
41. Need AG, O'Loughlin PD, Morris HA, et al.: The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 2004, 89:1646-1649.
42. Burns L, Ashwell M, Berry J, et al.: UK Food Standards Agency Optimal Nutrition Status Workshop: environmental factors that affect bone health throughout life. Br J Nutr 2003, 89:835-840. The UK Food Standards Agency (FSA) convened a group of expert scientists to discuss and review UK FSA- and Department of Health-funded research on diet and bone health. This research focused on the lifestyle factors that are amenable to change and may significantly affect bone health and the risk of osteoporotic fracture. The potential benefits of fruits and vegetables, meat, Ca, vitamins D and K, and phyto-oestrogens were presented and discussed. Other lifestyle factors were also discussed, particularly the effect of physical activity and possible gene-nutrient interactions affecting bone health.
43. Zittermann A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003, 89:552-572.
44. Heaney RP: Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr 2003, 78:912-919.
45. Malabanan AO, Holick MF: Vitamin D and bone health in postmenopausal women. J Womens Health 2003, 12:151-156.
46. Wu F, Staykova T, Horne A, et al.: Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 2003, 116:U536.
47. Tangpricha V, Koutkia P, Rieke SM, et al.: Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 2003, 77:1478-1483.
48. Lilliu H, Pamphile R, Chapuy MC, et al.: Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention. Maturitas 2003, 44:299-305.
49. Boonen S, Rizzoli R, Meunier PJ, et al.: The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 2004 (Apr 7 Epub ahead of print). The panel concluded that: (1) osteoporosis is a disease that requires continuing medical attention to ensure optimal therapeutic benefits; (2) when given in appropriate doses, calcium and vitamin D have been shown to be pharmacologically active (particularly in patients with dietary deficiencies), safe, and effective for the prevention and treatment of osteoporotic fractures; (3) calcium and vitamin D are an essential, but not sufficient, component of an integrated management strategy for the prevention and treatment of osteoporosis in patients with dietary insufficiencies, although maximal benefit in terms of fracture prevention requires the addition of antiresorptive therapy; (4) calcium and vitamin D are a cost-effective medication in the prevention and treatment of osteoporosis; (5) it is apparent that awareness of the efficacy of calcium and vitamin D in osteoporosis is still low and further work needs to be done to increase awareness among physicians, patients, and women at risk; and (6) in order that calcium and vitamin D continues to be manufactured to Good Manufacturing Practice standards and physicians and other health care professionals continue to provide guidance for the optimal use of these agents, they should continue to be classified as medicinal products.
50. Nieves JW, Cosman F: The treatment of osteoporosis and interaction of medications and nutrition. In Nutritional Aspects of Bone Health. Edited by New S, Bonjour JP. Cambridge, UK: The Royal Society for Chemistry; 2003.
51. American College of Obstetricians and Gynecologists: Women's Health Care Physicians. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2004, 103:203-216.
52. Adler RA, Hochberg MC: Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. Arch Intern Med 2003, 163:2619-2624.
53. Siris ES, Bilezikian JP, Rubin MR, et al.: Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 2003, 88:3482-3486.
54. Jackson RD, LaCroix AZ, Cauley JA, McGowan J: The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol 2003, 13(suppl 9):S98-106.